A Multi-Centered Randomized Phase II Study Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Everolimus (Primary) ; Carboplatin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 19 Apr 2017 Planned End Date changed from 1 Feb 2017 to 1 Jun 2018.
- 19 Apr 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Jun 2018.
- 25 Feb 2016 Planned End Date changed from 1 Jun 2016 to 1 Feb 2017, according to ClinicalTrials.gov record.